LATEST HEALTH NEWS
New multi-centric, phase-II, randomized, open-label clinical trial evaluates efficacy, safety and tolerability of NIclosamide for the treatment of hospitalized COVID-19 patients.
from Medindia Health News https://ift.tt/34W9PXy
No comments
Thanks for comment via will connect you within 24 hours.